Carbohydrate antigen 19-9 in cerebrospinal fluid and within malignant cells in a case of leptomeningeal carcinomatosis.
Sato
Y
Y
Ohta
Y
Y
Kaji
M
M
Oizumi
K
K
Kaji
M
M
D000230:Adenocarcinoma / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D000328:Adult; D018395:CA-19-9 Antigen / Q000134:cerebrospinal fluid*; D002555:Cerebrospinal Fluid / Q000166:cytology*; D003131:Combined Modality Therapy; D006801:Humans; D007124:Immunoenzyme Techniques; D008175:Lung Neoplasms / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D008577:Meningeal Neoplasms / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D008578:Meninges / Q000473:pathology; D009460:Neurologic Examination
D018395:CA-19-9 Antigen